Ikena Oncology
$205.92
7
+$189.48+1,152.55% Friday 20:00
Statistics
Day High
1.48
Day Low
1.36
52W High
23.28
52W Low
1.36
Volume
457,262
Avg. Volume
17,247
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
6NovExpected
Expected EPS
-0.98
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-49.23MNet Income
Analyst Ratings
16Average Price Target
The highest estimate is 30.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 0%
Sell 50%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IKNA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap1.1B
Agios Pharmaceuticals
AGIO
Mkt Cap1.93B
Incyte
INCY
Mkt Cap19.12B
Kura Oncology
KURA
Mkt Cap765.82M
Xencor
XNCR
Mkt Cap885.2M
Fate Therapeutics
FATE
Mkt Cap144.17M
Novartis
NVS
Mkt Cap297.35B
About
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Dr. Mark Manfredi Ph.D.
Employees
10
Country
United States
ISIN
US45175G1085
Listings
0 Comments
Share your thoughts
FAQ
What is Ikena Oncology stock price today?▼
The current price of IKNA is $205.92 USD — it has increased by +1,152.55% in the past 24 hours. Watch Ikena Oncology stock price performance more closely on the chart.
What is Ikena Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ikena Oncology stocks are traded under the ticker IKNA.
Is Ikena Oncology stock price growing?▼
IKNA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Ikena Oncology has showed a +1,405.26% increase.
What is Ikena Oncology revenue for the last year?▼
Ikena Oncology revenue for the last year amounts to 0 USD.
What is Ikena Oncology net income for the last year?▼
IKNA net income for the last year is -49.23M USD.
How many employees does Ikena Oncology have?▼
As of April 15, 2026, the company has 10 employees.
In which sector is Ikena Oncology located?▼
Ikena Oncology operates in the Health & Wellness sector.
When did Ikena Oncology complete a stock split?▼
The last stock split for Ikena Oncology was on July 28, 2025 with a ratio of 1:12.
Where is Ikena Oncology headquartered?▼
Ikena Oncology is headquartered in Boston, United States.